|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/113 | |
| A61K 31/711 | |||
| C07H 21/00 | |||
| A61P 25/00 | |||
| A61P 27/02 |
| (11) | Number of the document | 1699924 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04817632.5 |
| Date of filing the European patent application | 2004-12-03 | |
| (97) | Date of publication of the European application | 2006-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-09-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2004/004431 |
| Date | 2004-12-03 |
| (87) | Number | WO 2005/053600 |
| Date | 2005-06-16 |
| (30) | Number | Date | Country code |
| 529936 | 2003-12-03 | NZ |
| (72) |
LAUX, Wilda, NZ
GREEN, Colin, R., NZ
|
| (73) |
Ocunexus Therapeutics, Inc.,
101 West Broadway, Suite 900, San Diego, CA 92101,
US
|
| (54) | INHIBITORY COMPOUNDS TARGETED TO CONNEXIN 43 AND METHODS OF USE THEREOF IN THE TREATMENT OF CORNEAL EYE TRAUMA |
| INHIBITORY COMPOUNDS TARGETED TO CONNEXIN 43 AND METHODS OF USE THEREOF IN THE TREATMENT OF CORNEAL EYE TRAUMA |